secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vanda Pharmaceuticals Inc. (VNDA)
CIK:        0001347178
Form:       8-K
Filed at:   2024-05-03T23:59:59+00:00
Accession:  0001193125-24-130668
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vanda amends Rights Agreement to exempt BlackRock from poison pill up to 20% ownership
--------------------------------------------------------------------------------

- Amendment adds BlackRock and its managed funds as 'Exempt Person' under the Rights Agreement.
- BlackRock may acquire up to 20% of Vanda's common stock without triggering the poison pill.
- Exempt status can be revoked immediately if BlackRock breaches representations or conditions.
- The Board deems the amendment desirable based on BlackRock's representations and warranties.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1347178/000119312524130668/0001193125-24-130668-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1347178/000119312524130668/d833979d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-130668

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer